Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer : Anti-Cancer Drugs

Journal Logo

Original article

Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer

Wang, Mengfana,b,c,*; Ma, Zhub,c,*; Li, Qingsonga,b,c,*; Yang, Wenganga,b,c; Chen, Xiaxiaa,b,c; Geng, Yichaoa,c; Luo, Daxiana,c; Hu, Yinxianga,b,c; Wu, Biboa,b,c; Jiang, Weia,b,c; Su, Shengfaa,b,c; Ouyang, Weiweia,b,c; Lu, Binga,b,c

Author Information
Anti-Cancer Drugs ():10.1097/CAD.0000000000001501, January 24, 2023. | DOI: 10.1097/CAD.0000000000001501

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid